TMD: Effect of Massage Treatment in Temporomandibular Joint

Sponsor
Istanbul University (Other)
Overall Status
Completed
CT.gov ID
NCT04132726
Collaborator
(none)
90
1
3
17.5
5.1

Study Details

Study Description

Brief Summary

Temporomandibular disorders (TMD) have multiple and broad clinical effects on orofacial structures and are often diagnosed in patients with a prevalence of between 5% and 12%. Among treatment options, massage therapy is one of the common therapeutic procedures and allows interesting clinical outcomes by reducing TMD symptoms successfully. However, there has been no attempt to validate this knowledge. Thus, the aim of this study is to evaluate the effect of massage and its properties in patients with TMD.

Condition or Disease Intervention/Treatment Phase
  • Other: Massage therapy
  • Other: non-effective treatment
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect of Massage Treatment in Patients With Temporomandibular Disorder
Actual Study Start Date :
Apr 17, 2018
Actual Primary Completion Date :
Feb 23, 2019
Actual Study Completion Date :
Oct 2, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Test

Experimental group which employed with massage treatment

Other: Massage therapy
Massage therapy performed by a physiotherapist

Placebo Comparator: Placebo

Placebo group which employed with non-effective treatment

Other: non-effective treatment
non-effective treatment

No Intervention: Control

no treatment

Outcome Measures

Primary Outcome Measures

  1. Pain- Visual Analog Scale [12 weeks-14 weeks]

    Self-reported pain values. High scores for pain mean worse outcome for the study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Temporomandibular disorder-positive RDC/TMD examination for groups RDC/TMD Ia and RDC/TMD Ib,

  2. Patient agreement to participate in the experimental study.

Exclusion Criteria:
  1. RDC/TMD II and RDC/TMDIII,

  2. Drug and/or removable partial or total prosthesis wearers,

  3. Being submitted to any type of physiotherapeutic treatment,

  4. Incomplete dentition,

  5. History of systemic diseases as diabetes or arthritis,

  6. The occurrence of facial trauma,

  7. Refusal to assume responsibility with this research.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul university,Faculty of Dentistry Fatih Turkey 34452

Sponsors and Collaborators

  • Istanbul University

Investigators

  • Principal Investigator: Merve Benli, Dr., Istanbul University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Merve Benli, Asst.Prof.Dr., Istanbul University
ClinicalTrials.gov Identifier:
NCT04132726
Other Study ID Numbers:
  • 192021
First Posted:
Oct 21, 2019
Last Update Posted:
Oct 21, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Merve Benli, Asst.Prof.Dr., Istanbul University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 21, 2019